Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|November 16, 2025
Synthesis of novel 6-azacytidine prodrugs as potent influenza A inhibitorsOmar Moukha-Chafiq, Larry D Bratton, Shuklendu D Karyakarte, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 16, 2024
Identification of pyrimidine structure-based compounds as allosteric ligands of the dopamine transporter as therapeutic agents for NeuroHIVAna Catya Jimenez-Torres, Jamison A Hastie, Sarah E Davis, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2025
Identification of pyrimidine structure-based compounds as allosteric ligands of the dopamine transporter as therapeutic agents for NeuroHIVAna Catya Jimenez-Torres, Jamison A Hastie, Sarah E Davis, et al.
Antiviral Research|June 8, 2025
High-throughput screening for identification of influenza a inhibitors using a cell-based immunofluorescence assayYohanka Martinez-Gzegozewska, Lynn Rasmussen, N Miranda Nebane, et al.
Bioorganic & Medicinal Chemistry Letters|April 12, 2026
Design, synthesis and evaluation of novel BRD4 and RIPK3 dual inhibitors as potential anti-inflammatory agents and antidotes for arsenicalsOmar Moukha-Chafiq, Marina Fosso Yatchang, Kaitlyn Houghtling, et al.
European Journal of Medicinal Chemistry|January 25, 2020
Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused libraryGarrett S Gibbons, Amarraj Chakraborty, Sierrah M Grigsby, et al.
Molecular Therapy. Oncology|April 6, 2026
Identification of small molecules that enhance aminoglycoside-mediated suppression of CFTR and NF1 nonsense mutationsJoshua Sammons, Jianguo Chen, Kari Thrasher, et al.
Cell Metabolism|July 30, 2020
Identification of an Anti-diabetic, Orally Available Small Molecule that Regulates TXNIP Expression and Glucagon ActionLance A Thielen, Junqin Chen, Gu Jing, et al.
SLAS Discovery : Advancing Life Sciences R & D|July 4, 2025
High-throughput screening for the identification of dual inhibitors of BRD4 and RIPK3 toward the development of small-molecule medical countermeasure agents against arsenicalsMarina Fosso Yatchang, Ling Zhai, Omar Moukha-Chafiq, et al.
JCI Insight|September 21, 2018
A limb-girdle muscular dystrophy 2I model of muscular dystrophy identifies corrective drug compounds for dystroglycanopathiesPeter R Serafini, Michael J Feyder, Rylie M Hightower, et al.
Pageof 4